Offer - Urjas Oil for just ₹ 1 X
Telmizen AM is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Telmizen AM safe for pregnant women?
Telmizen AM should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Telmizen AM safe during breastfeeding?
There is no research available on the side effects of Telmizen AM in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Telmizen AM on the Kidneys?
Telmizen AM may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Telmizen AM on the Liver?
The liver can be affected by Telmizen AM. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Telmizen AM only after medical advice.
What is the effect of Telmizen AM on the Heart?
There are no any side effects of Telmizen AM for the heart.
Telmizen AM should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Telmizen AM unless your doctor advises you to do so -
Is this Telmizen AM habit forming or addictive?
Telmizen AM is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Telmizen AM as it does not make you drowsy.
Is it safe?
Yes, but consume Telmizen AM only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Telmizen AM for mental disorders.
Interaction between Food and Telmizen AM
Information is not available on the interaction of any foods with Telmizen AM, due to a lack of research on this.
Interaction between Alcohol and Telmizen AM
Taking [medicine] and alcohol at the same time may lead to mild side effects. Contact your doctor right away if you observe any side effects.
Telmizen AM contains telmisartan which is an antihypertensive drug that works by preventing a chemical (angiotensin II) to bind with a receptor. This causes relaxation of blood vessels, it also prevents the synthesis and release of aldosterone (a hormone whose hyperactivity results in high blood pressure). In this way Telmizen AM decreases the blood pressure.
Yes, Telmizen AM may cause a cough on rare occasions. If you experience a cough while taking Telmizen AM, please talk to your doctor immediately.
No, Telmizen AM is not a beta blocker/calcium channel blocker/diuretic/blood thinner/ace inhibitor. It is angiotensin II receptor blocker (an antihypertensive drug).
No, Telmizen AM doesn't cause a headache. However, if you experience a headache while using Telmizen AM, please consult your doctor without any delay.
No, Telmizen AM is not bad for kidneys. In fact, it protects the kidneys, thus, it is suitable for people with diabetes and mild-to-moderate kidney disease.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148